Does OBINUTUZUMAB Cause Vascular device infection? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Vascular device infection have been filed in association with OBINUTUZUMAB (Gazyva). This represents 0.1% of all adverse event reports for OBINUTUZUMAB.
10
Reports of Vascular device infection with OBINUTUZUMAB
0.1%
of all OBINUTUZUMAB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Vascular device infection From OBINUTUZUMAB?
Of the 10 reports, 2 (20.0%) required hospitalization.
Is Vascular device infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OBINUTUZUMAB. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
What Other Drugs Cause Vascular device infection?
TEDUGLUTIDE (1,009)
TREPROSTINIL (807)
EPOPROSTENOL (253)
TRASTUZUMAB (176)
MACITENTAN (168)
PERTUZUMAB (167)
AMBRISENTAN (162)
RITUXIMAB (155)
DOCETAXEL (137)
CYCLOPHOSPHAMIDE (122)
Which OBINUTUZUMAB Alternatives Have Lower Vascular device infection Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE